To ascertain that STAT3 is indeed the downstream mediator of miR-124’s inhibitory effect on cancer cell survival and in vivo tumor growth, we designed siRNA against STAT3 to specifically down-regulate STAT3 expression and seek to recapitulate the effect of miR-124 on CRC development. The gene discussed is STAT3; the disease is cancer.